Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Chronic Heart Failure

  Free Subscription


Articles published in Heart

Retrieve available abstracts of 203 articles:
HTML format



Single Articles


    August 2021
  1. RAMAKUMAR V, Arvind B, Deepti S
    A young man with acute heart failure and a holodiastolic murmur.
    Heart. 2021;107:1288-1356.
    PubMed    


    July 2021
  2. BOTS SH, Onland-Moret NC, Tulevski II, van der Harst P, et al
    Heart failure medication dosage and survival in women and men seen at outpatient clinics.
    Heart. 2021 Jul 14. pii: heartjnl-2021-319229. doi: 10.1136/heartjnl-2021-319229
    PubMed     Abstract available


    June 2021
  3. TAYLOR CJ, Lay-Flurrie SL, Ordonez-Mena JM, Goyder CR, et al
    Natriuretic peptide level at heart failure diagnosis and risk of hospitalisation and death in England 2004-2018.
    Heart. 2021 Jun 28. pii: heartjnl-2021-319196. doi: 10.1136/heartjnl-2021-319196
    PubMed     Abstract available


  4. DOCHERTY KF, Petrie MC
    Sodium-glucose cotransporter 2 inhibitors as a treatment for heart failure.
    Heart. 2021 Jun 14. pii: heartjnl-2020-318658. doi: 10.1136/heartjnl-2020-318658
    PubMed    


  5. MULDER BA, Rienstra M, Van Gelder IC, Blaauw Y, et al
    Update on management of atrial fibrillation in heart failure: a focus on ablation.
    Heart. 2021 Jun 4. pii: heartjnl-2020-318081. doi: 10.1136/heartjnl-2020-318081.
    PubMed     Abstract available


  6. DESAI RJ, Patorno E, Vaduganathan M, Mahesri M, et al
    Effectiveness of angiotensin-neprilysin inhibitor treatment versus renin-angiotensin system blockade in older adults with heart failure in clinical care.
    Heart. 2021 Jun 4. pii: heartjnl-2021-319405. doi: 10.1136/heartjnl-2021-319405.
    PubMed     Abstract available


  7. GRIFFIN J, Cheng R
    Real-world utilisation of angiotensin-neprilysin inhibitors in older adults with heart failure.
    Heart. 2021 Jun 4. pii: heartjnl-2021-319545. doi: 10.1136/heartjnl-2021-319545.
    PubMed    


    May 2021
  8. NICOLI CD, O'Neal WT, Levitan EB, Singleton MJ, et al
    Atrial fibrillation and risk of incident heart failure with reduced versus preserved ejection fraction.
    Heart. 2021 May 24. pii: heartjnl-2021-319122. doi: 10.1136/heartjnl-2021-319122
    PubMed     Abstract available


  9. DESJARDIN J, Leyde S, Davis J
    Weathering the perfect storm: management of heart failure in patients with substance use disorders.
    Heart. 2021 May 24. pii: heartjnl-2021-319103. doi: 10.1136/heartjnl-2021-319103
    PubMed    


  10. ROSSIDES M, Kullberg S, Grunewald J, Eklund A, et al
    Risk and predictors of heart failure in sarcoidosis in a population-based cohort study from Sweden.
    Heart. 2021 May 21. pii: heartjnl-2021-319129. doi: 10.1136/heartjnl-2021-319129
    PubMed     Abstract available


  11. CHUA W, Fabritz L
    Heart failure in patients with atrial fibrillation: why it matters now more than ever.
    Heart. 2021 May 13. pii: heartjnl-2021-319145. doi: 10.1136/heartjnl-2021-319145
    PubMed    


  12. LADOUCEUR M, Segura de la Cal T, Gaye B, Valentin E, et al
    Effect of medical treatment on heart failure incidence in patients with a systemic right ventricle.
    Heart. 2021 May 6. pii: heartjnl-2020-318787. doi: 10.1136/heartjnl-2020-318787.
    PubMed     Abstract available


    March 2021
  13. ROMAINE SPR, Denniff M, Codd V, Nath M, et al
    Telomere length is independently associated with all-cause mortality in chronic heart failure.
    Heart. 2021 Mar 31. pii: heartjnl-2020-318654. doi: 10.1136/heartjnl-2020-318654
    PubMed     Abstract available


  14. BOROVAC JA
    Neurohormones and death in systolic heart failure: keep your friends close, but your enemies closer.
    Heart. 2021 Mar 18. pii: heartjnl-2021-319153. doi: 10.1136/heartjnl-2021-319153
    PubMed    


  15. AIMO A, Prontera C, Passino C, Emdin M, et al
    Norepinephrine, plasma renin activity and cardiovascular mortality in systolic heart failure.
    Heart. 2021 Mar 12. pii: heartjnl-2020-318791. doi: 10.1136/heartjnl-2020-318791
    PubMed     Abstract available


  16. WEBER C, Hung J, Hickling S, Nedkoff L, et al
    Incidence, predictors and mortality risk of new heart failure in patients hospitalised with atrial fibrillation.
    Heart. 2021 Mar 11. pii: heartjnl-2020-318648. doi: 10.1136/heartjnl-2020-318648
    PubMed     Abstract available


  17. BUNTING KV, Gill SK, Sitch A, Mehta S, et al
    Improving the diagnosis of heart failure in patients with atrial fibrillation.
    Heart. 2021 Mar 10. pii: heartjnl-2020-318557. doi: 10.1136/heartjnl-2020-318557
    PubMed     Abstract available


    February 2021
  18. JOSHI SS, Singh T, Newby DE, Singh J, et al
    Sodium-glucose co-transporter 2 inhibitor therapy: mechanisms of action in heart failure.
    Heart. 2021 Feb 26. pii: heartjnl-2020-318060. doi: 10.1136/heartjnl-2020-318060
    PubMed     Abstract available


  19. LADOUCEUR M
    Heart failure in adults with congenital heart disease: a call for action.
    Heart. 2021 Feb 23. pii: heartjnl-2020-318757. doi: 10.1136/heartjnl-2020-318757
    PubMed    


  20. NISHIKAWA Y, Fukahori H, Mizuno A, Kwong JS, et al
    Cochrane corner: advance care planning for adults with heart failure.
    Heart. 2021 Feb 10. pii: heartjnl-2020-318458. doi: 10.1136/heartjnl-2020-318458
    PubMed    


  21. YAMAMOTO S, Yamaga T, Kawachi S, Shibuya M, et al
    Cochrane corner: Positive airway pressure therapy for the treatment of central sleep apnoea associated with heart failure.
    Heart. 2021 Feb 10. pii: heartjnl-2020-317888. doi: 10.1136/heartjnl-2020-317888
    PubMed    


    January 2021
  22. WU J, Hall AS, Gale CP
    Long-term survival benefit of ramipril in patients with acute myocardial infarction complicated by heart failure.
    Heart. 2021 Jan 15. pii: heartjnl-2020-316823. doi: 10.1136/heartjnl-2020-316823
    PubMed     Abstract available


  23. MOHEBALI D, Kittleson MM
    Remote monitoring in heart failure: current and emerging technologies in the context of the pandemic.
    Heart. 2021 Jan 11. pii: heartjnl-2020-318062. doi: 10.1136/heartjnl-2020-318062
    PubMed     Abstract available


  24. YANDRAPALLI S, Malik A, Pemmasani G, Aronow W, et al
    Sex differences in heart failure hospitalisation risk following acute myocardial infarction.
    Heart. 2021 Jan 11. pii: heartjnl-2020-318306. doi: 10.1136/heartjnl-2020-318306
    PubMed     Abstract available


  25. SANDERSON JE, Fang F, Lu M, Ma CY, et al
    Response to 'Obstructive sleep apnoea, intermittent hypoxia and heart failure with a preserved ejection fraction'.
    Heart. 2021 Jan 7. pii: heartjnl-2020-318849. doi: 10.1136/heartjnl-2020-318849.
    PubMed    


  26. ALBUQUERQUE LL, Meira E Cruz M, Salles C
    Obstructive sleep apnoea, intermittent hypoxia and heart failure with a preserved ejection fraction.
    Heart. 2021 Jan 7. pii: heartjnl-2020-318762. doi: 10.1136/heartjnl-2020-318762.
    PubMed    


    December 2020
  27. BLACHER M, Zimerman A, Engster PHB, Grespan E, et al
    Revisiting heart failure assessment based on objective measures in NYHA functional classes I and II.
    Heart. 2020 Dec 23. pii: heartjnl-2020-317984. doi: 10.1136/heartjnl-2020-317984
    PubMed     Abstract available


  28. BURSTEIN DS, Rossano JW, Griffis H, Zhang X, et al
    Greater admissions, mortality and cost of heart failure in adults with congenital heart disease.
    Heart. 2020 Dec 23. pii: heartjnl-2020-318246. doi: 10.1136/heartjnl-2020-318246
    PubMed     Abstract available


    November 2020
  29. HAMATANI Y, Iguchi M, Ueno K, Aono Y, et al
    Prognostic significance of natriuretic peptide levels in atrial fibrillation without heart failure.
    Heart. 2020 Nov 20. pii: heartjnl-2020-317735. doi: 10.1136/heartjnl-2020-317735
    PubMed     Abstract available


  30. REARDON L, Lin J
    Advanced heart failure and transplant in congenital heart disease.
    Heart. 2020 Nov 13. pii: heartjnl-2019-316366. doi: 10.1136/heartjnl-2019-316366
    PubMed    


  31. SANDERSON JE, Fang F, Lu M, Ma CY, et al
    Obstructive sleep apnoea, intermittent hypoxia and heart failure with a preserved ejection fraction.
    Heart. 2020 Nov 6. pii: heartjnl-2020-317326. doi: 10.1136/heartjnl-2020-317326.
    PubMed     Abstract available


  32. DROZD M, Relton SD, Walker AMN, Slater TA, et al
    Association of heart failure and its comorbidities with loss of life expectancy.
    Heart. 2020 Nov 5. pii: heartjnl-2020-317833. doi: 10.1136/heartjnl-2020-317833.
    PubMed     Abstract available


  33. ZIMERMAN A, Rohde LE
    Why do poor patients have poor outcomes? Shedding light on the neglected facet of poverty and heart failure.
    Heart. 2020 Nov 2. pii: heartjnl-2020-317977. doi: 10.1136/heartjnl-2020-317977.
    PubMed    


    October 2020
  34. HUNG CL, Chao TF, Su CH, Liao JN, et al
    Income level and outcomes in patients with heart failure with universal health coverage.
    Heart. 2020 Oct 20. pii: heartjnl-2020-316793. doi: 10.1136/heartjnl-2020-316793
    PubMed     Abstract available


  35. MULDER BA, Rienstra M, Blaauw Y
    Evaluation and treatment of premature ventricular contractions in heart failure with reduced ejection fraction.
    Heart. 2020 Oct 19. pii: heartjnl-2020-317491. doi: 10.1136/heartjnl-2020-317491
    PubMed     Abstract available


  36. BHATIA HS, Nishimura M, Dickson S, Adler E, et al
    Clinical and echocardiographic outcomes in heart failure associated with methamphetamine use and cessation.
    Heart. 2020 Oct 5. pii: heartjnl-2020-317635. doi: 10.1136/heartjnl-2020-317635.
    PubMed     Abstract available


  37. KAPLON-CIESLICKA A, Lund LH
    Atrial fibrillation in heart failure with preserved ejection fraction: a risk marker, risk factor or confounder?
    Heart. 2020 Oct 5. pii: heartjnl-2020-317978. doi: 10.1136/heartjnl-2020-317978.
    PubMed    


  38. MOCERI P, Lopez S, Ferrari E
    Atypical right heart failure in a septuagenarian.
    Heart. 2020;106:1524-1536.
    PubMed    


    September 2020
  39. BERGLUND F, Pina P, Herrera CJ
    Right ventricle in heart failure with preserved ejection fraction.
    Heart. 2020 Sep 7. pii: heartjnl-2020-317342. doi: 10.1136/heartjnl-2020-317342.
    PubMed     Abstract available


    August 2020
  40. PERRY AS, Mann DL, Brown DL
    Improvement of ejection fraction and mortality in ischaemic heart failure.
    Heart. 2020 Aug 25. pii: heartjnl-2020-316975. doi: 10.1136/heartjnl-2020-316975
    PubMed     Abstract available


  41. ZHANG X, Wang S, Liu J, Wang Y, et al
    D-dimer and the incidence of heart failure and mortality after acute myocardial infarction.
    Heart. 2020 Aug 12. pii: heartjnl-2020-316880. doi: 10.1136/heartjnl-2020-316880
    PubMed     Abstract available


  42. SCHRAGE B, Lund LH, Benson L, Stolfo D, et al
    Lower socioeconomic status predicts higher mortality and morbidity in patients with heart failure.
    Heart. 2020 Aug 7. pii: heartjnl-2020-317216. doi: 10.1136/heartjnl-2020-317216.
    PubMed     Abstract available


    July 2020
  43. AL-MOHAMMAD A
    NICE heart failure guidelines: the diagnostic algorithm in practice, what is the next step?
    Heart. 2020 Jul 20. pii: heartjnl-2020-317450. doi: 10.1136/heartjnl-2020-317450
    PubMed    


  44. ZHENG A, Cowan E, Mach L, Adam RD, et al
    Characteristics and outcomes of patients with suspected heart failure referred in line with National Institute for Health and Care Excellence guidance.
    Heart. 2020 Jul 20. pii: heartjnl-2019-316511. doi: 10.1136/heartjnl-2019-316511
    PubMed     Abstract available


  45. DARDAS T, Dorsch MP
    Remote management of heart failure: Herculean or Sisyphean task?
    Heart. 2020 Jul 9. pii: heartjnl-2020-317270. doi: 10.1136/heartjnl-2020-317270.
    PubMed    


    June 2020
  46. RAHIMI K, Nazarzadeh M, Pinho-Gomes AC, Woodward M, et al
    Home monitoring with technology-supported management in chronic heart failure: a randomised trial.
    Heart. 2020 Jun 24. pii: heartjnl-2020-316773. doi: 10.1136/heartjnl-2020-316773
    PubMed     Abstract available


  47. MARINI C, Fragasso G, Italia L, Sisakian H, et al
    Lung ultrasound-guided therapy reduces acute decompensation events in chronic heart failure.
    Heart. 2020 Jun 22. pii: heartjnl-2019-316429. doi: 10.1136/heartjnl-2019-316429
    PubMed     Abstract available


  48. ROSANO G, Savarese G
    Inter-twinned relationship between heart failure and atrial fibrillation.
    Heart. 2020 Jun 1. pii: heartjnl-2020-316886. doi: 10.1136/heartjnl-2020-316886.
    PubMed    


    April 2020
  49. SON MK, Park JJ, Lim NK, Kim WH, et al
    Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
    Heart. 2020 Apr 27. pii: heartjnl-2019-316219. doi: 10.1136/heartjnl-2019-316219
    PubMed     Abstract available


  50. HONG SH, Lee JS, Kim JA, Lee YB, et al
    Gamma-glutamyl transferase variability and the risk of hospitalisation for heart failure.
    Heart. 2020 Apr 17. pii: heartjnl-2019-316271. doi: 10.1136/heartjnl-2019-316271
    PubMed     Abstract available


  51. OTTO CM
    Heartbeat: risk of stroke in patients with heart failure.
    Heart. 2020;106:549-551.
    PubMed    


    March 2020
  52. KRISAI P, Blum S, Aeschbacher S, Beer JH, et al
    Associations of symptoms and quality of life with outcomes in patients with atrial fibrillation.
    Heart. 2020 Mar 31. pii: heartjnl-2019-316314. doi: 10.1136/heartjnl-2019-316314
    PubMed     Abstract available


  53. OTTO CM
    Heartbeat: can machine learning improve outcomes in patients with heart failure with preserved ejection fraction?
    Heart. 2020;106:315-317.
    PubMed    


  54. CHEN S, Banerjee A
    Machine learning: a long way from implementation in cardiovascular disease.
    Heart. 2020;106:318-320.
    PubMed    


    February 2020
  55. ERGATOUDES C, Hansson PO, Svardsudd K, Rosengren A, et al
    Comparison of incidence rates and risk factors of heart failure between two male cohorts born 30 years apart.
    Heart. 2020 Feb 29. pii: heartjnl-2019-316059. doi: 10.1136/heartjnl-2019-316059
    PubMed     Abstract available


  56. CHEHAB O, Roberts-Thomson R, Ng Yin Ling C, Marber M, et al
    Secondary mitral regurgitation: pathophysiology, proportionality and prognosis.
    Heart. 2020 Feb 13. pii: heartjnl-2019-316238. doi: 10.1136/heartjnl-2019-316238
    PubMed     Abstract available


  57. BANERJEE A
    Ethnicity, heart failure and the prevention continuum: time to act.
    Heart. 2020 Feb 6. pii: heartjnl-2019-316293. doi: 10.1136/heartjnl-2019-316293.
    PubMed    


  58. BEGUE C, Morner S, Brito D, Hengstenberg C, et al
    Mid-regional proatrial natriuretic peptide for predicting prognosis in hypertrophic cardiomyopathy.
    Heart. 2020;106:196-202.
    PubMed     Abstract available


  59. TOBLER D, Greutmann M
    Simple cardiac shunts in adults: atrial septal defects, ventricular septal defects, patent ductus arteriosus.
    Heart. 2020;106:307-314.
    PubMed    


  60. SANTIAGO DE ARAUJO PIO C, Chaves G, Davies P, Taylor R, et al
    Cochrane corner: increasing patient utilisation of cardiac rehabilitation.
    Heart. 2020;106:248-250.
    PubMed    


    January 2020
  61. NELSON AJ, Patel MR
    Ischaemic stroke in heart failure: back to basics?
    Heart. 2020 Jan 27. pii: heartjnl-2019-315957. doi: 10.1136/heartjnl-2019-315957
    PubMed    


  62. HEDMAN AK, Hage C, Sharma A, Brosnan MJ, et al
    Identification of novel pheno-groups in heart failure with preserved ejection fraction using machine learning.
    Heart. 2020 Jan 7. pii: heartjnl-2019-315481. doi: 10.1136/heartjnl-2019-315481.
    PubMed     Abstract available


  63. GALLEGO P, Oliver JM
    Medical therapy for heart failure in adult congenital heart disease: does it work?
    Heart. 2020;106:154-162.
    PubMed    


    December 2019
  64. UEBERHAM L, Konig S, Hohenstein S, Mueller-Roething R, et al
    Sex differences of resource utilisation and outcomes in patients with atrial arrhythmias and heart failure.
    Heart. 2019 Dec 19. pii: heartjnl-2019-315566. doi: 10.1136/heartjnl-2019-315566
    PubMed     Abstract available


  65. OSTERGAARD L, Dahl A, Bruun NE, Oestergaard LB, et al
    Valve regurgitation in patients surviving endocarditis and the subsequent risk of heart failure.
    Heart. 2019 Dec 10. pii: heartjnl-2019-315715. doi: 10.1136/heartjnl-2019-315715
    PubMed     Abstract available


  66. WOOD K, Gladwin M, Straub A
    Sickle cell disease: at the crossroads of pulmonary hypertension and diastolic heart failure.
    Heart. 2019 Dec 10. pii: heartjnl-2019-314810. doi: 10.1136/heartjnl-2019-314810
    PubMed     Abstract available


    October 2019
  67. CHOU YL, Liou JT, Cheng CC, Tsai MC, et al
    The association of ischaemic stroke in patients with heart failure without atrial flutter/fibrillation.
    Heart. 2019 Oct 3. pii: heartjnl-2019-315646. doi: 10.1136/heartjnl-2019-315646.
    PubMed     Abstract available


  68. OTTO CM
    Heartbeat: oxygen transport close to and far from the ventricle in heart failure.
    Heart. 2019;105:1525-1527.
    PubMed    


    September 2019
  69. MAHAJAN R, Stokes M, Elliott A, Munawar DA, et al
    Complex interaction of obesity, intentional weight loss and heart failure: a systematic review and meta-analysis.
    Heart. 2019 Sep 17. pii: heartjnl-2019-314770. doi: 10.1136/heartjnl-2019-314770
    PubMed     Abstract available


  70. AHN MS, Yoo BS, Yoon J, Lee SH, et al
    Guideline-directed therapy at discharge in patients with heart failure and atrial fibrillation.
    Heart. 2019 Sep 6. pii: heartjnl-2019-315240. doi: 10.1136/heartjnl-2019-315240.
    PubMed     Abstract available


  71. BERNARD S, Hung J
    Managing tricuspid valve regurgitation: a long and winding road.
    Heart. 2019 Sep 6. pii: heartjnl-2019-315696. doi: 10.1136/heartjnl-2019-315696.
    PubMed    


    August 2019
  72. RODRIGUES BS, David C, Costa J, Ferreira JJ, et al
    Influenza vaccination in patients with heart failure: a systematic review and meta-analysis of observational studies.
    Heart. 2019 Aug 23. pii: heartjnl-2019-315193. doi: 10.1136/heartjnl-2019-315193
    PubMed     Abstract available


  73. REDDY YNV, Nishimura R
    Intervening for tricuspid regurgitation: uncertainties in a heterogeneous syndrome.
    Heart. 2019 Aug 23. pii: heartjnl-2019-315624. doi: 10.1136/heartjnl-2019-315624
    PubMed    


  74. ZHANG H, El-Am EA, Thaden JJ, Pislaru SV, et al
    Atrial fibrillation is not an independent predictor of outcome in patients with aortic stenosis.
    Heart. 2019 Aug 22. pii: heartjnl-2019-314996. doi: 10.1136/heartjnl-2019-314996
    PubMed     Abstract available


  75. KADRI AN, Menon V, Sammour YM, Gajulapalli RD, et al
    Outcomes of patients with severe tricuspid regurgitation and congestive heart failure.
    Heart. 2019 Aug 17. pii: heartjnl-2019-315004. doi: 10.1136/heartjnl-2019-315004
    PubMed     Abstract available


  76. FROEHLICH L, Meyre P, Aeschbacher S, Blum S, et al
    Left atrial dimension and cardiovascular outcomes in patients with and without atrial fibrillation: a systematic review and meta-analysis.
    Heart. 2019 Aug 17. pii: heartjnl-2019-315174. doi: 10.1136/heartjnl-2019-315174
    PubMed     Abstract available


    July 2019
  77. SILLARS A, Ho FK, Pell GP, Gill JMR, et al
    Sex differences in the association of risk factors for heart failure incidence and mortality.
    Heart. 2019 Jul 31. pii: heartjnl-2019-314878. doi: 10.1136/heartjnl-2019-314878
    PubMed     Abstract available


  78. WANG F, Harel-Sterling L, Cohen S, Liu A, et al
    Heart failure risk predictions in adult patients with congenital heart disease: a systematic review.
    Heart. 2019 Jul 26. pii: heartjnl-2019-314977. doi: 10.1136/heartjnl-2019-314977
    PubMed     Abstract available


  79. LUMBERS RT, Martin N, Manoharan K, Thomas J, et al
    Do beta-blockers and inhibitors of the renin-angiotensin aldosterone system improve outcomes in patients with heart failure and left ventricular ejection fraction >40%?
    Heart. 2019 Jul 25. pii: heartjnl-2018-313855. doi: 10.1136/heartjnl-2018-313855
    PubMed    


  80. NEPPER-CHRISTENSEN L, Hofsten DE, Helqvist S, Lassen JF, et al
    Interaction of ischaemic postconditioning and thrombectomy in patients with ST-elevation myocardial infarction.
    Heart. 2019 Jul 17. pii: heartjnl-2019-314952. doi: 10.1136/heartjnl-2019-314952
    PubMed     Abstract available


  81. CROSSLAND DS, Jansen K, Parry G, Harper A, et al
    Outcome following heart transplant assessment in adults with congenital heart disease.
    Heart. 2019 Jul 5. pii: heartjnl-2019-314711. doi: 10.1136/heartjnl-2019-314711.
    PubMed     Abstract available


    June 2019
  82. HEARON CM JR, Sarma S, Dias KA, Hieda M, et al
    Impaired oxygen uptake kinetics in heart failure with preserved ejection fraction.
    Heart. 2019 Jun 17. pii: heartjnl-2019-314797. doi: 10.1136/heartjnl-2019-314797
    PubMed     Abstract available


  83. CLARK AL, Kalra PR, Petrie MC, Mark PB, et al
    Change in renal function associated with drug treatment in heart failure: national guidance.
    Heart. 2019;105:904-910.
    PubMed     Abstract available


  84. TAN ESJ, Tay WT, Teng TK, Richards AM, et al
    The diabetes-atrial fibrillation paradox.
    Heart. 2019;105:893.
    PubMed    


  85. GERDTS E, Saeed S, Midtbo H, Rossebo A, et al
    Higher left ventricular mass-wall stress-heart rate product and outcome in aortic valve stenosis.
    Heart. 2019 Jun 1. pii: heartjnl-2018-314462. doi: 10.1136/heartjnl-2018-314462.
    PubMed     Abstract available


    May 2019
  86. ONG G, Pibarot P
    Combined aortic stenosis and regurgitation: double the trouble.
    Heart. 2019 May 29. pii: heartjnl-2017-312303. doi: 10.1136/heartjnl-2017-312303
    PubMed    


  87. SCHICHTEL M, Wee B, Perera R, Onakpoya I, et al
    Clinician-targeted interventions to improve advance care planning in heart failure: a systematic review and meta-analysis.
    Heart. 2019 May 22. pii: heartjnl-2019-314758. doi: 10.1136/heartjnl-2019-314758
    PubMed     Abstract available


  88. OTTO CM
    Heartbeat: Primary care delays in heart failure diagnosis.
    Heart. 2019;105:661-662.
    PubMed    


    April 2019
  89. SALAH K, Stienen S, Pinto YM, Eurlings LW, et al
    Prognosis and NT-proBNP in heart failure patients with preserved versus reduced ejection fraction.
    Heart. 2019 Apr 8. pii: heartjnl-2018-314173. doi: 10.1136/heartjnl-2018-314173.
    PubMed     Abstract available


  90. BEGGS SAS, Rorth R, Gardner RS, McMurray JJV, et al
    Anticoagulation therapy in heart failure and sinus rhythm: a systematic review and meta-analysis.
    Heart. 2019 Apr 8. pii: heartjnl-2018-314381. doi: 10.1136/heartjnl-2018-314381.
    PubMed     Abstract available


  91. GALLAGHER C, Hendriks JM, Giles L, Karnon J, et al
    Increasing trends in hospitalisations due to atrial fibrillation in Australia from 1993 to 2013.
    Heart. 2019 Apr 1. pii: heartjnl-2018-314471. doi: 10.1136/heartjnl-2018-314471.
    PubMed     Abstract available


    March 2019
  92. CHRISTIANSEN MN, Kober L, Torp-Pedersen C, Smith JG, et al
    Prevalence of heart failure and other risk factors among first-degree relatives of women with peripartum cardiomyopathy.
    Heart. 2019 Mar 25. pii: heartjnl-2018-314552. doi: 10.1136/heartjnl-2018-314552
    PubMed     Abstract available


  93. ANDERSON LJ, Squire IB, Cowie MR
    Global lessons from deaths from heart failure in UK hospitals.
    Heart. 2019 Mar 2. pii: heartjnl-2018-314641. doi: 10.1136/heartjnl-2018-314641.
    PubMed    


    February 2019
  94. FROHLICH H, Rosenfeld N, Tager T, Goode K, et al
    Epidemiology and long-term outcome in outpatients with chronic heart failure in Northwestern Europe.
    Heart. 2019 Feb 21. pii: heartjnl-2018-314256. doi: 10.1136/heartjnl-2018-314256
    PubMed     Abstract available


  95. BURDEN AF, Timpson N
    Ethnicity, heart failure, atrial fibrillation and diabetes: collider bias.
    Heart. 2019 Feb 6. pii: heartjnl-2018-314467. doi: 10.1136/heartjnl-2018-314467.
    PubMed    



  96. Correction: Heart rate: surrogate or target in the management of heart failure?
    Heart. 2019;105:e1.
    PubMed    


    January 2019
  97. EZEKOWITZ JA
    Creating order out of chaos: quality of care in heart failure.
    Heart. 2019 Jan 31. pii: heartjnl-2018-314526. doi: 10.1136/heartjnl-2018-314526
    PubMed    


  98. AGARWAL A, Bahiru E, Yoo SGK, Berendsen MA, et al
    Hospital-based quality improvement interventions for patients with heart failure: a systematic review.
    Heart. 2019 Jan 30. pii: heartjnl-2018-314129. doi: 10.1136/heartjnl-2018-314129
    PubMed     Abstract available


  99. PINHO-GOMES AC, Rahimi K
    Management of blood pressure in heart failure.
    Heart. 2019 Jan 23. pii: heartjnl-2018-314438. doi: 10.1136/heartjnl-2018-314438
    PubMed     Abstract available


  100. TAN ESJ, Tay WT, Teng TK, Sim D, et al
    Ethnic differences in atrial fibrillation in patients with heart failure from Asia-Pacific.
    Heart. 2019 Jan 19. pii: heartjnl-2018-314077. doi: 10.1136/heartjnl-2018-314077
    PubMed     Abstract available


  101. TAYLOR CJ
    Diagnosing heart failure: challenges in primary care.
    Heart. 2019 Jan 15. pii: heartjnl-2018-314396. doi: 10.1136/heartjnl-2018-314396
    PubMed    


  102. DIMOPOULOS K, Muthiah K, Alonso-Gonzalez R, Banner NR, et al
    Heart or heart-lung transplantation for patients with congenital heart disease in England.
    Heart. 2019 Jan 12. pii: heartjnl-2018-313984. doi: 10.1136/heartjnl-2018-313984
    PubMed     Abstract available


  103. OTTO CM
    Heartbeat: heart failure induced by cancer therapy.
    Heart. 2019;105:1-3.
    PubMed    


    December 2018
  104. NAKATSUMA K, Taniguchi T, Morimoto T, Shiomi H, et al
    B-type natriuretic peptide in patients with asymptomatic severe aortic stenosis.
    Heart. 2018 Dec 7. pii: heartjnl-2018-313746. doi: 10.1136/heartjnl-2018-313746.
    PubMed     Abstract available


  105. HAYHOE B, Kim D, Aylin PP, Majeed FA, et al
    Adherence to guidelines in management of symptoms suggestive of heart failure in primary care.
    Heart. 2018 Dec 4. pii: heartjnl-2018-313971. doi: 10.1136/heartjnl-2018-313971.
    PubMed     Abstract available


  106. DEFARIA YEH D, Stefanescu Schmidt AC, Eisman AS, Serfas JD, et al
    Impaired right ventricular reserve predicts adverse cardiac outcomes in adults with congenital right heart disease.
    Heart. 2018;104:2044-2050.
    PubMed     Abstract available


    October 2018
  107. AL RIFAI M, Blaha MJ, Rahman F, Ehrman JK, et al
    Inverse association of pulse pressure augmentation during exercise with heart failure and death.
    Heart. 2018 Oct 25. pii: heartjnl-2018-313736. doi: 10.1136/heartjnl-2018-313736
    PubMed     Abstract available


  108. MILANI GP, Bianchetti MG, Lava SA
    Measurement of sodium in heart failure.
    Heart. 2018;104:1724.
    PubMed    


  109. BUBER J, Valente AM
    Predicting survival in adults with congenital heart disease: what are the odds?
    Heart. 2018;104:1643-1644.
    PubMed    


    September 2018
  110. NTILOUDI D, Apostolopoulou S, Vasiliadis K, Frogoudaki A, et al
    Hospitalisations for heart failure predict mortality in pulmonary hypertension related to congenital heart disease.
    Heart. 2018 Sep 29. pii: heartjnl-2018-313613. doi: 10.1136/heartjnl-2018-313613
    PubMed     Abstract available


  111. LEE SE, Lee HY, Cho HJ, Choe WS, et al
    Coronary artery bypass graft versus percutaneous coronary intervention in acute heart failure.
    Heart. 2018 Sep 12. pii: heartjnl-2018-313242. doi: 10.1136/heartjnl-2018-313242
    PubMed     Abstract available


  112. BHAGRA SK, Pettit S, Parameshwar J
    Cardiac transplantation: indications, eligibility and current outcomes.
    Heart. 2018 Sep 12. pii: heartjnl-2018-313103. doi: 10.1136/heartjnl-2018-313103
    PubMed    


  113. DIBBEN GO, Dalal HM, Taylor RS, Doherty P, et al
    Cardiac rehabilitation and physical activity: systematic review and meta-analysis.
    Heart. 2018;104:1394-1402.
    PubMed     Abstract available


  114. KRUPICKOVA S, Morgan GJ, Cheang MH, Rigby ML, et al
    Symptomatic partial and transitional atrioventricular septal defect repaired in infancy.
    Heart. 2018;104:1411-1416.
    PubMed     Abstract available


    August 2018
  115. SZE S, Pellicori P, Zhang J, Clark AL, et al
    Malnutrition, congestion and mortality in ambulatory patients with heart failure.
    Heart. 2018 Aug 18. pii: heartjnl-2018-313312. doi: 10.1136/heartjnl-2018-313312
    PubMed     Abstract available


  116. WOLFSON AM, Fong M, Grazette L, Rahman JE, et al
    Chronic heart failure management and remote haemodynamic monitoring.
    Heart. 2018 Aug 18. pii: heartjnl-2018-313397. doi: 10.1136/heartjnl-2018-313397
    PubMed     Abstract available


  117. HUANG W, Su L, Wu S, Xu L, et al
    Long-term outcomes of His bundle pacing in patients with heart failure with left bundle branch block.
    Heart. 2018 Aug 9. pii: heartjnl-2018-313415. doi: 10.1136/heartjnl-2018-313415.
    PubMed     Abstract available


  118. SULTAN I, Cardounel A, Abdelkarim I, Kilic A, et al
    Right ventricle to pulmonary artery coupling in patients undergoing transcatheter aortic valve implantation.
    Heart. 2018 Aug 9. pii: heartjnl-2018-313385. doi: 10.1136/heartjnl-2018-313385.
    PubMed     Abstract available


  119. HUTCHINGS DC, Anderson SG, Caldwell JL, Trafford AW, et al
    Phosphodiesterase-5 inhibitors and the heart: compound cardioprotection?
    Heart. 2018;104:1244-1250.
    PubMed     Abstract available


  120. CHOUSOU PA, Pugh PJ
    How to deliver optimal cardiac resynchronisation therapy.
    Heart. 2018;104:1300-1307.
    PubMed    


    July 2018
  121. PRASAD SB, Holland DJ, Atherton JJ
    Diastolic stress echocardiography: from basic principles to clinical applications.
    Heart. 2018 Jul 20. pii: heartjnl-2017-312323. doi: 10.1136/heartjnl-2017-312323
    PubMed     Abstract available


  122. LYON AR
    Heart failure resulting from cancer treatment: still serious but an opportunity for prevention.
    Heart. 2018 Jul 4. pii: heartjnl-2018-313493. doi: 10.1136/heartjnl-2018-313493.
    PubMed    


  123. KUMAR N
    Does the purported mortality benefit of beta-blocker therapy in heart failure with a preserved ejection fraction apply to patients without prior myocardial infarction?
    Heart. 2018;104:1135.
    PubMed    


  124. NANCHEN D
    Resting heart rate: what is normal?
    Heart. 2018;104:1048-1049.
    PubMed    


  125. JARVIE JL, Metz TD, Davis MB, Ehrig JC, et al
    Short-term risk of cardiovascular readmission following a hypertensive disorder of pregnancy.
    Heart. 2018;104:1187-1194.
    PubMed     Abstract available


    June 2018
  126. OTTO CM
    Heartbeat: socioeconomic deprivation is associated with non-cardiovascular mortality in chronic heart failure patients.
    Heart. 2018;104:961-963.
    PubMed    


  127. ZHU K, Knuiman M, Divitini M, Murray K, et al
    High-sensitivity cardiac troponin I and risk of cardiovascular disease in an Australianpopulation-based cohort.
    Heart. 2018;104:895-903.
    PubMed     Abstract available


  128. FRANCIS R, Lewis C
    Myocardial biopsy: techniques and indications.
    Heart. 2018;104:950-958.
    PubMed    


    May 2018
  129. NG AT, Duan L, Win T, Spencer HT, et al
    Maternal and fetal outcomes in pregnant women with heart failure.
    Heart. 2018 May 25. pii: heartjnl-2018-313156. doi: 10.1136/heartjnl-2018-313156
    PubMed     Abstract available


  130. NADRUZ W JR, West E, Sengelov M, Grove GL, et al
    Cardiovascular phenotype and prognosis of patients with heart failure induced by cancer therapy.
    Heart. 2018 May 15. pii: heartjnl-2018-313234. doi: 10.1136/heartjnl-2018-313234
    PubMed     Abstract available


    April 2018
  131. APPS A, Lau J, Peterzan M, Neubauer S, et al
    Hyperpolarised magnetic resonance for in vivo real-time metabolic imaging.
    Heart. 2018 Apr 27. pii: heartjnl-2017-312356. doi: 10.1136/heartjnl-2017-312356
    PubMed     Abstract available


  132. LARSSON SC, Drca N, Bjorck M, Back M, et al
    Nut consumption and incidence of seven cardiovascular diseases.
    Heart. 2018 Apr 16. pii: heartjnl-2017-312819. doi: 10.1136/heartjnl-2017-312819
    PubMed     Abstract available


  133. ROHDE LE, Beck-da-Silva L
    Alcohol and the heart: the good, the bad and the worse in heart failure.
    Heart. 2018 Apr 5. pii: heartjnl-2017-312924. doi: 10.1136/heartjnl-2017-312924.
    PubMed    


  134. GUPTA D, Masoud A, Bartoletti S
    The Authors' reply.
    Heart. 2018;104:626.
    PubMed    


  135. OTTO CM
    Heartbeat: phenotypic heterogeneity of bicuspid aortic valve disease.
    Heart. 2018;104:541-543.
    PubMed    


    March 2018
  136. B SCHNABEL R, Pecen L, Engler D, Lucerna M, et al
    Atrial fibrillation patterns are associated with arrhythmia progression and clinical outcomes.
    Heart. 2018 Mar 17. pii: heartjnl-2017-312569. doi: 10.1136/heartjnl-2017-312569
    PubMed     Abstract available


  137. BETTENCOURT P, Lourenco P
    Atrial fibrillation, a difficulty in the heart failure screening with natriuretic peptides.
    Heart. 2018 Mar 16. pii: heartjnl-2017-312910. doi: 10.1136/heartjnl-2017-312910
    PubMed    


  138. VAN DOORN S, Geersing GJ, Kievit RF, van Mourik Y, et al
    Opportunistic screening for heart failure with natriuretic peptides in patients with atrial fibrillation: a meta-analysis of individual participant data of four screening studies.
    Heart. 2018 Mar 16. pii: heartjnl-2017-312781. doi: 10.1136/heartjnl-2017-312781
    PubMed     Abstract available


  139. NADRUZ W JR, Gioli-Pereira L, Bernardez-Pereira S, Marcondes-Braga FG, et al
    Temporal trends in the contribution of Chagas cardiomyopathy to mortality among patients with heart failure.
    Heart. 2018 Mar 9. pii: heartjnl-2017-312869. doi: 10.1136/heartjnl-2017-312869.
    PubMed     Abstract available


  140. OTTO CM
    Heartbeat: Is there any effective therapy for heart failure with preserved ejection fraction?
    Heart. 2018;104:361-362.
    PubMed    


  141. WAGNER F, Gebauer RA, Paech C
    Newborn in cardiogenic shock.
    Heart. 2018;104:467.
    PubMed     Abstract available


    February 2018
  142. COWIE MR, Zakeri R
    Preventing stroke in patients with heart failure: why are patients losing out?
    Heart. 2018 Feb 2. pii: heartjnl-2017-312862. doi: 10.1136/heartjnl-2017-312862.
    PubMed    


  143. WILSON AJ, Gill EK, Abudalo RA, Edgar KS, et al
    Reactive oxygen species signalling in the diabetic heart: emerging prospect for therapeutic targeting.
    Heart. 2018;104:293-299.
    PubMed     Abstract available


    January 2018
  144. WITTE KK, Patel PA, Walker AMN, Schechter CB, et al
    Socioeconomic deprivation and mode-specific outcomes in patients with chronic heart failure.
    Heart. 2018 Jan 31. pii: heartjnl-2017-312539. doi: 10.1136/heartjnl-2017-312539
    PubMed     Abstract available


  145. SQUIRE I
    Socioeconomic status and outcomes in heart failure with reduced ejection fraction.
    Heart. 2018 Jan 25. pii: heartjnl-2017-312814. doi: 10.1136/heartjnl-2017-312814
    PubMed    


  146. SAVARESE G, Sartipy U, Friberg L, Dahlstrom U, et al
    Reasons for and consequences of oral anticoagulant underuse in atrial fibrillation with heart failure.
    Heart. 2018 Jan 25. pii: heartjnl-2017-312720. doi: 10.1136/heartjnl-2017-312720
    PubMed     Abstract available


  147. WANG YC, Huang CW, Lin TW
    Acute heart failure with new-onset continuous murmur in a 26-year-old man.
    Heart. 2018 Jan 11. pii: heartjnl-2017-312506. doi: 10.1136/heartjnl-2017-312506
    PubMed     Abstract available


  148. ZAKERI R, Cowie MR
    Heart failure with preserved ejection fraction: controversies, challenges and future directions.
    Heart. 2018 Jan 5. pii: heartjnl-2016-310790. doi: 10.1136/heartjnl-2016-310790.
    PubMed     Abstract available


  149. FRAGASSO G
    Age-related reduction of myocardial metabolic efficiency: Is it time to routinely measure myocardial metabolism to monitor cardiac health?
    Heart. 2018;104:88-89.
    PubMed    


  150. NATHANIA M, Hollingsworth KG, Bates M, Eggett C, et al
    Impact of age on the association between cardiac high-energy phosphate metabolism and cardiac power in women.
    Heart. 2018;104:111-118.
    PubMed     Abstract available


    December 2017
  151. MCMURRAY JJV, Trueman D, Hancock E, Cowie MR, et al
    Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction.
    Heart. 2017 Dec 21. pii: heartjnl-2016-310661. doi: 10.1136/heartjnl-2016-310661
    PubMed     Abstract available


  152. MARTENS P, Verbrugge FH, Nijst P, Dupont M, et al
    Incremental benefit of cardiac resynchronisation therapy with versus without a defibrillator.
    Heart. 2017;103:1977-1984.
    PubMed     Abstract available


  153. ROUX V, Salaun E, Tribouilloy C, Hubert S, et al
    Coronary events complicating infective endocarditis.
    Heart. 2017;103:1906-1910.
    PubMed     Abstract available


  154. RAO P, Faddis M
    Cardiac resynchronisation therapy: current indications, management and basic troubleshooting.
    Heart. 2017;103:2000-2007.
    PubMed    


    November 2017
  155. KIM TH, Kim H, Kim IC, Yoon HJ, et al
    Heart rate at first postdischarge visit and outcomes in patients with heart failure.
    Heart. 2017 Nov 25. pii: heartjnl-2017-312364. doi: 10.1136/heartjnl-2017-312364
    PubMed     Abstract available


  156. MORTON G, Masters J, Cowburn PJ
    Multidisciplinary team approach to heart failure management.
    Heart. 2017 Nov 23. pii: heartjnl-2016-310598. doi: 10.1136/heartjnl-2016-310598
    PubMed    


  157. HUTCHINGS DC, Anderson SG, Trafford AW
    Phosphodiesterase-5 inhibitors as novel cardioprotective agents: have we reached threshold for large-scale clinical trials?
    Heart. 2017;103:1745.
    PubMed    


    October 2017
  158. LEE H, Lee SE, Park CS, Park JJ, et al
    Hyponatraemia and its prognosis in acute heart failure is related to right ventricular dysfunction.
    Heart. 2017 Oct 27. pii: heartjnl-2017-312084. doi: 10.1136/heartjnl-2017-312084
    PubMed     Abstract available


  159. CHOI KH, Lee GY, Choi JO, Jeon ES, et al
    Outcomes of de novo and acute decompensated heart failure patients according to ejection fraction.
    Heart. 2017 Oct 5. pii: heartjnl-2017-311813. doi: 10.1136/heartjnl-2017-311813.
    PubMed     Abstract available


  160. BOTTLE A, Kim D, Aylin P, Cowie MR, et al
    Routes to diagnosis of heart failure: observational study using linked data in England.
    Heart. 2017 Oct 5. pii: heartjnl-2017-312183. doi: 10.1136/heartjnl-2017-312183.
    PubMed     Abstract available


  161. PETRIE MC, Rocchiccioli P
    Coronary angiography in heart failure: when and why? Uncertainty reigns.
    Heart. 2017 Oct 5. pii: heartjnl-2017-312200. doi: 10.1136/heartjnl-2017-312200.
    PubMed    


  162. SINGH JSS, Burrell LM, Cherif M, Squire IB, et al
    Sacubitril/valsartan: beyond natriuretic peptides.
    Heart. 2017;103:1569-1577.
    PubMed     Abstract available


  163. OHUCHI H, Negishi J, Hayama Y, Miyazaki A, et al
    Renal resistive index reflects Fontan pathophysiology and predicts mortality.
    Heart. 2017;103:1631-1637.
    PubMed     Abstract available


    August 2017
  164. SCHNELL F, Donal E
    Pharmacological strategies in heart failure with preserved ejection fraction: time for an individualised treatment strategy?
    Heart. 2017 Aug 18. pii: heartjnl-2017-312119. doi: 10.1136/heartjnl-2017-312119
    PubMed    


  165. FERREIRA JP, Rossignol P, Demissei B, Sharma A, et al
    Coronary angiography in worsening heart failure: determinants, findings and prognostic implications.
    Heart. 2017 Aug 10. pii: heartjnl-2017-311750. doi: 10.1136/heartjnl-2017-311750
    PubMed     Abstract available


  166. ZHENG SL, Chan FT, Nabeebaccus AA, Shah AM, et al
    Drug treatment effects on outcomes in heart failure with preserved ejection fraction: a systematic review and meta-analysis.
    Heart. 2017 Aug 5. pii: heartjnl-2017-311652. doi: 10.1136/heartjnl-2017-311652.
    PubMed     Abstract available


    July 2017
  167. TUEGEL C, Bansal N
    Heart failure in patients with kidney disease.
    Heart. 2017 Jul 17. pii: heartjnl-2016-310794. doi: 10.1136/heartjnl-2016-310794
    PubMed     Abstract available


  168. SCHMIDT M
    Interaction between body mass index and physical fitness in primary heart failure prevention.
    Heart. 2017 Jul 17. pii: heartjnl-2017-311504. doi: 10.1136/heartjnl-2017-311504
    PubMed    


  169. MINAMINO-MUTA E, Kato T, Morimoto T, Taniguchi T, et al
    Impact of the left ventricular mass index on the outcomes of severe aortic stenosis.
    Heart. 2017 Jul 6. pii: heartjnl-2016-311022. doi: 10.1136/heartjnl-2016-311022.
    PubMed     Abstract available


  170. D'AMARIO D, Amodeo A, Adorisio R, Tiziano FD, et al
    A current approach to heart failure in Duchenne muscular dystrophy.
    Heart. 2017 Jul 1. pii: heartjnl-2017-311269. doi: 10.1136/heartjnl-2017-311269.
    PubMed     Abstract available


  171. GROGAN M, Dispenzieri A, Gertz MA
    Light-chain cardiac amyloidosis: strategies to promote early diagnosis and cardiac response.
    Heart. 2017;103:1065-1072.
    PubMed     Abstract available


    June 2017
  172. FISHER SA, Doree C, Mathur A, Taggart DP, et al
    Cochrane Corner: stem cell therapy for chronic ischaemic heart disease and congestive heart failure.
    Heart. 2017 Jun 12. pii: heartjnl-2017-311684. doi: 10.1136/heartjnl-2017-311684
    PubMed    


  173. ROHDE LE, Biolo A
    The tip of the iceberg in the sub-Saharan Africa: unraveling the real world in the diagnosis and treatment of heart failure.
    Heart. 2017 Jun 5. pii: heartjnl-2017-311558. doi: 10.1136/heartjnl-2017-311558.
    PubMed    


    May 2017
  174. CRUMP C, Sundquist J, Winkleby MA, Sundquist K, et al
    Aerobic fitness, muscular strength and obesity in relation to risk of heart failure.
    Heart. 2017 May 12. pii: heartjnl-2016-310716. doi: 10.1136/heartjnl-2016-310716
    PubMed     Abstract available


  175. CARLSON S, Duber HC, Achan J, Ikilezi G, et al
    Capacity for diagnosis and treatment of heart failure in sub-Saharan Africa.
    Heart. 2017 May 10. pii: heartjnl-2016-310913. doi: 10.1136/heartjnl-2016-310913
    PubMed     Abstract available


  176. KUTYIFA V
    Gender-specific outcomes of cardiac resynchronisation therapy with or without defibrillator.
    Heart. 2017;103:732-733.
    PubMed    


  177. OTTO CM
    Heartbeat: Cardiac resynchronization therapy with or without defibrillation: are women different?
    Heart. 2017;103:727-728.
    PubMed    


    April 2017
  178. AMBALE-VENKATESH B, Yoneyama K, Sharma RK, Ohyama Y, et al
    Left ventricular shape predicts different types of cardiovascular events in the general population.
    Heart. 2017;103:499-507.
    PubMed     Abstract available


    March 2017
  179. OTTO CM
    Heartbeat: Diabetes and heart failure.
    Heart. 2017;103:327-328.
    PubMed    


  180. OTTO CM
    Heartbeat:Blood urea nitrogen to creatinine ratio predicts outcome in acute heart failure.
    Heart. 2017;103:399-401.
    PubMed    


    February 2017
  181. ROSMINI S, Biagini E, O'Mahony C, Bulluck H, et al
    Relationship between aetiology and left ventricular systolic dysfunction in hypertrophic cardiomyopathy.
    Heart. 2017;103:300-306.
    PubMed     Abstract available


    January 2017
  182. BARRA S, Providencia R, Duehmke R, Boveda S, et al
    Sex-specific outcomes with addition of defibrillation to resynchronisation therapy in patients with heart failure.
    Heart. 2017 Jan 19. pii: heartjnl-2016-310677. doi: 10.1136/heartjnl-2016-310677
    PubMed     Abstract available


    December 2016
  183. SCHRANZ D, Akintuerk H, Voelkel NF
    'End-stage' heart failure therapy: potential lessons from congenital heart disease: from pulmonary artery banding and interatrial communication to parallel circulation.
    Heart. 2016 Dec 23. pii: heartjnl-2015-309110. doi: 10.1136/heartjnl-2015-309110
    PubMed     Abstract available


  184. KINUGASA Y, Yamamoto K
    The challenge of frailty and sarcopenia in heart failure with preserved ejection fraction.
    Heart. 2016 Dec 9. pii: heartjnl-2016-309995. doi: 10.1136/heartjnl-2016-309995.
    PubMed     Abstract available


  185. OTTO CM
    Heartbeat: Heart failure and obstructive lung disease: are beta-blockers underused?
    Heart. 2016;102:1855-1856.
    PubMed    


  186. BURCHILL LJ
    Heart transplantation in adult congenital heart disease.
    Heart. 2016;102:1871-1877.
    PubMed     Abstract available


    November 2016
  187. INGLIS SC, Clark RA, Dierckx R, Prieto-Merino D, et al
    Structured telephone support or non-invasive telemonitoring for patients with heart failure.
    Heart. 2016 Nov 18. pii: heartjnl-2015-309191. doi: 10.1136/heartjnl-2015-309191
    PubMed    


    October 2016
  188. CHIMURA M, Onishi T, Tsukishiro Y, Sawada T, et al
    Longitudinal strain combined with delayed-enhancement magnetic resonance improves risk stratification in patients with dilated cardiomyopathy.
    Heart. 2016 Oct 31. pii: heartjnl-2016-309746. doi: 10.1136/heartjnl-2016-309746
    PubMed     Abstract available


  189. TAJIK AA, Dickstein K
    What constitutes optimal neurohumoral antagonism in chronic heart failure?
    Heart. 2016 Oct 14. pii: heartjnl-2015-308039. doi: 10.1136/heartjnl-2015-308039
    PubMed    


  190. NUNEZ J
    Blood urea nitrogen to creatinine ratio in acute heart failure: an old concept brought to reality?
    Heart. 2016 Oct 14. pii: heartjnl-2016-310536. doi: 10.1136/heartjnl-2016-310536
    PubMed    


  191. CEDIEL G, Gonzalez-Del-Hoyo M, Carrasquer A, Sanchez R, et al
    Outcomes with type 2 myocardial infarction compared with non-ischaemic myocardial injury.
    Heart. 2016 Oct 14. pii: heartjnl-2016-310243. doi: 10.1136/heartjnl-2016-310243
    PubMed     Abstract available


  192. BANSAL N, Szpiro A, Masoudi F, Greenlee RT, et al
    Kidney function and appropriateness of device therapies in adults with implantable cardioverter defibrillators.
    Heart. 2016 Oct 14. pii: heartjnl-2016-309842. doi: 10.1136/heartjnl-2016-309842
    PubMed     Abstract available


    September 2016
  193. RAHIMI K
    The long and unfinished journey of hyperglycaemia and heart failure research.
    Heart. 2016 Sep 29. pii: heartjnl-2016-310336. doi: 10.1136/heartjnl-2016-310336
    PubMed    


  194. NAIR A, Sajeev CG, Muneer K
    A case of recent myocardial infarction with cardiac failure.
    Heart. 2016 Sep 29. pii: heartjnl-2016-309715. doi: 10.1136/heartjnl-2016-309715
    PubMed     Abstract available


  195. MATSUE Y, van der Meer P, Damman K, Metra M, et al
    Blood urea nitrogen-to-creatinine ratio in the general population and in patients with acute heart failure.
    Heart. 2016 Sep 22. pii: heartjnl-2016-310112. doi: 10.1136/heartjnl-2016-310112
    PubMed     Abstract available


  196. NASR E, Ibrahim M, Yacoub M
    Heart failure in a neonate with multiple cardiac masses.
    Heart. 2016 Sep 21. pii: heartjnl-2016-310251. doi: 10.1136/heartjnl-2016-310251
    PubMed     Abstract available


  197. OU SM, Chen HT, Kuo SC, Chen TJ, et al
    Dipeptidyl peptidase-4 inhibitors and cardiovascular risks in patients with pre-existing heart failure.
    Heart. 2016 Sep 19. pii: heartjnl-2016-309687. doi: 10.1136/heartjnl-2016-309687
    PubMed     Abstract available


  198. SKRTIC S, Cabrera C, Olsson M, Schnecke V, et al
    Contemporary risk estimates of three HbA1c variables in relation to heart failure following diagnosis of type 2 diabetes.
    Heart. 2016 Sep 19. pii: heartjnl-2016-309806. doi: 10.1136/heartjnl-2016-309806
    PubMed     Abstract available


  199. KIM CH, Al-Kindi SG, Jandali B, Askari AD, et al
    Incidence and risk of heart failure in systemic lupus erythematosus.
    Heart. 2016 Sep 9. pii: heartjnl-2016-309561. doi: 10.1136/heartjnl-2016-309561.
    PubMed     Abstract available


    June 2016
  200. DHILLON A, Khanna A, Randhawa MS, Cywinski J, et al
    Perioperative outcomes of patients with hypertrophic cardiomyopathy undergoing non-cardiac surgery.
    Heart. 2016 Jun 10. pii: heartjnl-2016-309442. doi: 10.1136/heartjnl-2016-309442
    PubMed     Abstract available


    February 2016
  201. LAM CS, Lund LH
    Microvascular endothelial dysfunction in heart failure with preserved ejection fraction.
    Heart. 2016;102:257-9.
    PubMed    


  202. OTTO CM
    Heartbeat: Microvascular dysfunction in heart failure with preserved ejection fraction.
    Heart. 2016;102:255-6.
    PubMed    


    December 2015
  203. HODES AR, Tichnell C, Te Riele AS, Murray B, et al
    Pregnancy course and outcomes in women with arrhythmogenic right ventricular cardiomyopathy.
    Heart. 2015 Dec 30. pii: heartjnl-2015-308624. doi: 10.1136/heartjnl-2015-308624
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Chronic Heart Failure is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: